Idiopathic pulmonary fibrosis : new concepts in pathogenesis and implications for drug therapy
about
Phosphodiesterase 6 subunits are expressed and altered in idiopathic pulmonary fibrosis.FoxO3a (Forkhead Box O3a) deficiency protects Idiopathic Pulmonary Fibrosis (IPF) fibroblasts from type I polymerized collagen matrix-induced apoptosis via caveolin-1 (cav-1) and Fas.Panax notoginseng Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice.Survivin expression induced by endothelin-1 promotes myofibroblast resistance to apoptosis.iTRAQ-Based Proteomics Reveals Novel Biomarkers for Idiopathic Pulmonary Fibrosis.Mesenchymal cell fate and phenotypes in the pathogenesis of emphysemaX-linked inhibitor of apoptosis regulates lung fibroblast resistance to Fas-mediated apoptosis.Peptide-mediated inhibition of mitogen-activated protein kinase-activated protein kinase-2 ameliorates bleomycin-induced pulmonary fibrosisA novel single-chain Fv antibody for connective tissue growth factor against the differentiation of fibroblast into myofibroblast.Modulation of TGFbeta1-dependent myofibroblast differentiation by hyaluronanIncreased survivin expression contributes to apoptosis-resistance in IPF fibroblasts.Endothelin-1 and transforming growth factor-beta1 independently induce fibroblast resistance to apoptosis via AKT activation.Potential of imatinib mesylate as a novel treatment for pulmonary fibrosis.Epithelium-dependent profibrotic milieu in the pathogenesis of idiopathic pulmonary fibrosis: current status and future directions.
P2860
Q34332085-4574FA17-8AE7-4980-854C-B398393ED451Q34666156-F20E2DB8-5691-43F8-8BAA-E13693A20D4AQ34674295-A2BB6DA1-BE02-40E8-AFF6-4B0A124C5504Q35621434-A1F36F57-258C-492C-9B8E-03E992DCDD2DQ36259789-10C27A9C-CF8F-427C-ADE7-022DC418E9D7Q36473190-BD0702B5-57BA-4E6D-B613-EBBB9B334392Q37056479-B8B6822E-C372-4340-99D0-22AECF106392Q37056483-154A18AD-1B1F-49C9-8681-C72AB9832CBAQ39429905-17BE4651-2F95-4537-840D-AB0A9B9781B1Q39835446-39F0B2E2-3FD1-4331-9417-78D1C9A5DE12Q42155716-F5DF8523-B419-4C3D-AEFF-A4D7E59C482CQ42560002-15226680-639B-414A-9B35-5C3CC116D758Q43061664-4A680DA2-88BD-4E36-AD14-283A68D85F9DQ51233185-C22C6347-4631-4108-AD91-553BAE90037A
P2860
Idiopathic pulmonary fibrosis : new concepts in pathogenesis and implications for drug therapy
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Idiopathic pulmonary fibrosis ...... implications for drug therapy
@ast
Idiopathic pulmonary fibrosis ...... implications for drug therapy
@en
type
label
Idiopathic pulmonary fibrosis ...... implications for drug therapy
@ast
Idiopathic pulmonary fibrosis ...... implications for drug therapy
@en
prefLabel
Idiopathic pulmonary fibrosis ...... implications for drug therapy
@ast
Idiopathic pulmonary fibrosis ...... implications for drug therapy
@en
P2860
P1476
Idiopathic pulmonary fibrosis ...... implications for drug therapy
@en
P2093
Jeffrey C Horowitz
Victor J Thannickal
P2860
P304
P356
10.2165/00151829-200605050-00004
P577
2006-01-01T00:00:00Z
P5875
P6179
1000726252